IL139594A0 - Novel formulation containing paroxetine - Google Patents

Novel formulation containing paroxetine

Info

Publication number
IL139594A0
IL139594A0 IL13959499A IL13959499A IL139594A0 IL 139594 A0 IL139594 A0 IL 139594A0 IL 13959499 A IL13959499 A IL 13959499A IL 13959499 A IL13959499 A IL 13959499A IL 139594 A0 IL139594 A0 IL 139594A0
Authority
IL
Israel
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
novel
Prior art date
Application number
IL13959499A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL139594A0 publication Critical patent/IL139594A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13959499A 1998-05-13 1999-05-13 Novel formulation containing paroxetine IL139594A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
IL139594A0 true IL139594A0 (en) 2002-02-10

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13959499A IL139594A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (ru)
JP (1) JP2002514591A (ru)
KR (1) KR20010043574A (ru)
CN (1) CN1308521A (ru)
AP (1) AP2000002019A0 (ru)
AU (1) AU3940999A (ru)
BG (1) BG105010A (ru)
BR (1) BR9910401A (ru)
CA (1) CA2331871A1 (ru)
EA (1) EA200001174A1 (ru)
GB (1) GB9810181D0 (ru)
HU (1) HUP0102064A2 (ru)
ID (1) ID28019A (ru)
IL (1) IL139594A0 (ru)
NO (1) NO20005683L (ru)
PL (1) PL344573A1 (ru)
SK (1) SK17142000A3 (ru)
TR (1) TR200003350T2 (ru)
WO (1) WO1999058113A2 (ru)
ZA (1) ZA200006562B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EA002034B1 (ru) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Композиция на основе пароксетина
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida

Also Published As

Publication number Publication date
ZA200006562B (en) 2002-02-13
GB9810181D0 (en) 1998-07-08
HUP0102064A2 (hu) 2002-05-29
ID28019A (id) 2001-05-03
WO1999058113A3 (en) 2000-02-17
NO20005683D0 (no) 2000-11-10
TR200003350T2 (tr) 2001-03-21
AP2000002019A0 (en) 2000-12-31
AU3940999A (en) 1999-11-29
BR9910401A (pt) 2001-01-09
WO1999058113A2 (en) 1999-11-18
NO20005683L (no) 2000-12-05
PL344573A1 (en) 2001-11-05
EP1077682A2 (en) 2001-02-28
SK17142000A3 (sk) 2001-06-11
EA200001174A1 (ru) 2001-06-25
CN1308521A (zh) 2001-08-15
CA2331871A1 (en) 1999-11-18
BG105010A (en) 2001-07-31
KR20010043574A (ko) 2001-05-25
JP2002514591A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
EP1016400A4 (en) COMPOSITION FOR EXTERNAL USE
PT1466615E (pt) Composição farmacêutica
GB9809058D0 (en) Composition
PL343769A1 (en) Pharmaceutical composition
GB9818591D0 (en) Pharmaceutical composition
GB9812119D0 (en) Composition
PL334568A1 (en) Paroxetin containing compositions
GB9806788D0 (en) Composition
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
IL136106A0 (en) Formulations comprising dissolved paroxetine
GB9806793D0 (en) Composition
PL344872A1 (en) Novel formulation containing paroxetine
EP1124557A4 (en) PHARMACEUTICAL COMPOSITION
PL343095A1 (en) Paroxetine compositions
GB9809507D0 (en) Novel composition
GB2331703B (en) Disinfectant compositions
IL139594A0 (en) Novel formulation containing paroxetine
GB9804041D0 (en) Composition
GB9904523D0 (en) Platinum (11) compounds
HU9800078D0 (en) Pharmaceutical composition
GB9806791D0 (en) Composition
GB9818905D0 (en) Novel formulation
GB9818910D0 (en) Novel formulation
GB9800011D0 (en) Composition